Introduction
The global pandemic of Coronavirus Disease 19 (COVID-19) continues to impose enormous burdens on morbidity and mortality.1–3 COVID-19 is a fatal viral disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus strain that has spread all over the world and has become a serious public health problem.4 On March 11, 2020, the World Health Organization (WHO) pronounced the COVID-19 to be pandemic. At present, the illness has impacted 223 nations, producing more than 133.978 million recorded cases and 2.9 million fatalities.5,6
COVID-19 typically affects the respiratory system with a range of symptoms from asymptomatic to severe respiratory distress syndrome.7,8 The elderly and people with a history of co-morbid conditions like hypertension, obesity, diabetes, and kidney disease are typically more fatally affected by this virus.9,10 Due to their poor health infrastructure and training, African countries are more vulnerable to the spread of disease.11 Additionally, their inability to quickly receive the vaccination raises the danger of disease spread.12 Vaccination programs for Africans may be further delayed by vaccine-related expenses and transfer problems until late 2021 or early 2022. The majority of globally recognized vaccinations were purchased by developed nations.13
Different COVID-19 prevention strategies, including the implementation of lockdowns and quarantines, social isolation tactics, constant facemasking, travel limitations, and personal hygiene were implemented across the world.14–17 However, these have had a significant negative impact on people’s health and psychological well-being as well as a dramatic drop in the world economy.18 International efforts to create an effective prevention strategy to keep epidemics under control have increased due to the COVID-19 outbreak’s multifaceted disastrous effects.19,20
It has long been believed that immunizations are the most effective way to stop the spread of infectious diseases.13,21 Ethiopian health authorities opted to use the COVID-19 vaccine of Astra Zeneca through the COVAX Facility. As a result, on March 7, 2021, the nation received 2.184 million doses of COVID-19 vaccination. At a high-profile national event conducted at the Eka Kotebe COVID-19 Hospital on March 13, 2021, the Ethiopian Ministry of Health debuted the COVID-19 vaccine and marked the beginning of the immunization campaign by immunizing front-line healthcare workers.5 Literatures estimated that up to 82% of the population should be vaccinated to develop herd immunity against SARS-CoV- 2.21 The success of COVID-19 vaccination program will largely depend on people’s acceptance of the vaccine.22 However, rumors and conspiracy theories aimed at preventing the introduction of the new COVID-19 vaccine are spreading all over the world.23 Hence, vaccine hesitancy has become a key challenge for COVID-19 management.1,21 Many Ethiopians are reluctant to receive the COVID-19 vaccine.24–27,29,30 Forty eight percent of the study populations are unsure about the COVID-19 vaccines, according to a global assessment of possible COVID-19 vaccine approval.5 Consequently, in May 2020, the 73rd World Health Assembly passed a resolution endorsing broad immunization as a global public health objective for halting the spread of SARS-CoV-2.30 Some of the factors affecting COVID-19 vaccine acceptance are demographic and psychosocial correlates such gender, age, faith in research, comprehension and concerns about the novel immunization, people’s judgment and beliefs about COVID-19 danger, as well as risk exposure.22,31,32
The college years are a crucial time for establishing healthy habits and decision-making procedures. Adopting favorable health behaviors, such as accepting immunizations, may be influenced by having sufficient knowledge and using trustworthy information sources.33 A number of circumstances, including shared residence in on-campus and off-campus accommodation, the reopening of college campuses and activities, and the need to travel between their place of residence and campus, make college students vulnerable to SARS-Cov-2 infection. In addition, it has been determined that college campuses are susceptible to COVID-19 instances and have the potential to spread the virus to nearby populations.34 Greater acceptance of the COVID-19 vaccine was found in an Italian study of college students, medical students, students who had already had the flu shot, students who had a higher level of COVID-19 worry, and students who were very vulnerable to the disease.35 There is no research conducted on COVID-19 vaccination among college students in Ethiopia. Therefore, the study aimed to assess the acceptance and determinant factors of COVID-19 vaccine among college students in Dessie city, Northeastern Ethiopia.
Methods and Materials
Study Design, Period, and Setting
An institutional-based cross-sectional study was conducted in Dessie City, Northeastern Ethiopia, from July 1–20, 2021, to evaluate college students’ perceptions of the COVID-19 vaccine. Dessie town is found in South Wollo Zone, Amhara region of Northeastern Ethiopia. The city is situated in a mountainous area 480 kilometers from Bahirdar, the Amhara Region’s main city, and 401 kilometers north of Addis Ababa. A total of 23,507 students are engaged in three public institutions, one private university, and eight private colleges.
Populations of the Study
The source population of the study was all college students in Dessie city during the data collection time. On the other hand, the study population was college students from randomly selected colleges (Alkan, Tropical, Admass, Unity, and Dessie health science) found in Dessie city.
Inclusion and Exclusion Criteria
The study involved all college students who volunteered to take part. Students who were unable to answer because of a serious sickness or another personal reason, however, were not included in the study.
Sample Size Determination and Sampling Technique
Using the single population proportion formula, the sample size was calculated as 384 with the assumptions of Zα/2 at 95% CI = 1.96, an estimate of the proportion (p) of 50%, and a margin of error (d) of 5%. The study’s final sample size, after accounting for non-response rates of 10%, was 422. Five colleges out of a total of 12 were initially chosen using a simple random sampling technique. The number of participants from each chosen college was then distributed proportionally based on the enrollment at each college at the time the data were collected. Then, using a lottery system, departments were chosen at random. Each department provided a list of every student in the chosen departments. The study participants were selected using a simple random sampling technique using the lists of the students from their registrar offices’ as a sampling frame.
Operational Definitions
Vaccine acceptance is defined as the willingness of the study participants to receive the COVID-19 vaccine. The participants were then asked if they would be interested in receiving the COVID-19 vaccine, with the options being Yes or No. Yes responses received a score of “1”, and No responses received a score of “0.”36
Data Collection and Quality Assurances
The data was collected using a structured questionnaire adapted from previous published papers23–27,29,30,34,37–41 and contextualized according to the study setting. The questionnaire consists of socio-demographic characteristics of the participants, socio-political perception and attitude towards COVID-19 vaccine, and willingness towards the acceptance of COVID-19 vaccine. The questionnaire was initially written in English, then translated into the local language (Amharic) for the purpose of gathering data, and finally retranslated back into English to ensure consistency. The validity of the questionnaire was pre-tested using 5% of the study sample size. The feedback from pre-test was used for the amendment of the questionnaire, including avoiding of repeated questions, less irrelevant questions, and unclear questions. Data collectors and supervisors received training on the purpose of the study and the questionnaire’s components. Four nursing professionals administered the interviewer, while two MSc. public health experts provided oversight. To reduce data entering errors, double data entry was used. There were no missing records. Data cleaning was then done before statistical analysis.
Data Processing and Analysis
Data cleaning and analysis were carried out using the Statistical Package for Social Science (SPSS) version 25.0 after being exported from the Epi-Data software version 4.6. The study’s findings were represented using descriptive statistics. The association between independent variables and the willingness to accept COVID-19 vaccine was determined using a binary logistic regression analysis at 95% CI. Binary logistic regression with a 95% CI was used to analyze the data using bivariable analysis (COR, or crude odds ratio), as well as multivariable analysis (AOR, or adjusted odds ratio). Variables from the bivariable analysis that had p-values under 0.25 were kept for the multivariable analysis. Then, in a multivariate analysis, the variables were selected as significant predictors of college students’ willingness to accept the COVID-19 vaccine at a 95% CI when the p-value was less than 0.05. Using the standard error at the threshold value of −2 to +2, the presence of multicollinearity among the study’s independent variables was examined for each variable, but none of them revealed it. Additionally, the Hosmer–Lemeshow test was used to determine the model’s fitness, and we discovered a fit model with a p-value of 0.894 which was fit to run further statistical analysis.
Ethical Consideration
The study was carried out in accordance with the Helsinki Declaration. The ethical clearance was obtained from College of Medicine and Health Sciences, Wollo University. Higher officials of the chosen college granted permission for the study to be carried out. All participants were told of the study’s purpose and goals before participating, and participation was anonymous. Each study participant provided their written consent. Those who did not want to participate have the option of being excluded from the study. The data collection was done in compliance with the COVID-19 preventative strategies that were advised.
Results
Socio-Demographic Characteristics of the Respondents
In the current study, 422 college students participated in the study with a response rate of 95.6%. More than one-third 163 (40.5%) of the participants were males and less than half 186 (46.3%) of the participants were in the age range of 18–20 years. More than three fourth of the respondents 316 (78.6%) were single. Besides, lower than half 188 (46.8%) of the respondents were attending health science fields. Furthermore, only 27 (6.5%) of the participants had faced one or more chronic medical illness conditions and 35 (8.7%) had history of COVID-19 infection. On the other hand, slightly more than half, 212 (52.7%) of the study participants took training about COVID-19 vaccine. The current finding also revealed that about half 199 (49.5%) of the respondents used health insurance and 214 (51.9%) of the participants knew anyone diagnosed with COVID-19. Regarding the sources of information about COVID-19 vaccine, majority 345 (85.8%) of the respondents used peers as a source of information followed by mass-media such as (TV and radio) 243 (60.4%) (Table 1).
Enlarge this image.Table 1 Socio-Demographic Characteristics of College Students in Dessie City, Northeastern Ethiopia
Perception and Attitude Towards COVID-19 Vaccine
The finding of the present study revealed that three-fifth 244 (60.7%) of the participants perceived that COVID-19 infection is severe for human beings. On the other hand, more than two-thirds 281 (69.9%) of the participants agreed that the infection of COVID-19 can be prevented by vaccination. Besides, nearly three-quarter 298 (74.1%) of the respondents trust the government of Ethiopia towards the current COVID-19 vaccination. Additionally, near two-thirds 265 (65.9%) of the respondents perceived that the vaccine of COVID-19 infection is safe, while 278 (69.2%) perceived the vaccine is effective against the disease causing virus. Finally, this study pointed that more than half 226 (56.2%) of the participants had a willingness to accept of COVID-19 vaccine (Table 2).
Enlarge this image.Table 2 Perception and Attitude Towards COVID-19 Vaccine Among College Students in Dessie City, Northeastern Ethiopia
Factors Associated with the Acceptance of COVID-19 Vaccine
According to a multivariable logistic regression analysis, history of chronic medical illness, training on COVID-19 vaccine, history of regular vaccine uptake, perception of COVID-19 severity, perception that COVID-19 can be prevented by vaccine, and the development of herd immunity against COVID-19 vaccines were all factors that were significantly associated with willingness to accept COVID-19 vaccine among college students in Dessie, Northeastern Ethiopia. The current finding revealed that participants who had a history of chronic medical illness were four times more likely to accept COVID-19 vaccine (AOR: 4.340, 95% CI: 1.166, 16.149) than those who did not have chronic medical illness. Participants who had training on COVID-19 vaccine were four times more likely to accept COVID-19 vaccine (AOR: 4.755, 95% CI: 2.606, 6.674) than those who did not take training on COVID-19 vaccine. Besides, participants who had history of regular vaccine uptake were two times more likely to accept COVID-19 vaccine (AOR: 2.534, 95% CI: 1.412, 4.549) than those who did not have a history of vaccine uptake. Participants who perceived that COVID-19 is severe infection were four times more likely to accept COVID-19 vaccine (AOR: 4.109, 95% CI: 2.190, 7.710) than the corresponding groups who perceived COVID-19 is not severe infection. In addition, participants who perceived that COVID-19 can be prevented by vaccine were two times more likely to accept COVID-19 vaccine (AOR: 2.420, 95% CI: 1.160, 5.049) than the corresponding groups who perceived COVID-19 cannot be prevented by vaccine. Moreover, participants who perceived as they did not develop herd immunity against COVID-19 were two times more likely to accept COVID-19 vaccine (AOR: 2.566, 95% CI: 1.431, 4.599) than the corresponding groups (Table 3).
Enlarge this image.Table 3 Factors Associated with Willingness of COVID-19 Vaccine Acceptance Among College Students in Dessie City, Northeastern Ethiopia
Discussion
An institutional-based cross-sectional study design was implemented among college students in Dessie city, Northeastern Ethiopia from July 10–30, 2021. The study was aimed to assess the acceptance and determinant factors of COVID-19 vaccine among college students of Dessie city Northeastern Ethiopia. The urgency for vaccination is growing by the day, with increasing numbers of cases and reports of the virus variants across the world.24 For many years, vaccinations have been regarded as the most effective way to combat infectious diseases that spread quickly, including COVID-19.2,13 The effectiveness of this method will be determined by the rate of vaccination acceptance, which is based on a risk-benefit analysis.1,39 However, vaccine hesitancy and misinformation are obstacles to establishing high coverage and community immunity against COVID-19 infection.1,13 Vaccinations have long been seen to be the most effective way to combat quickly spreading infectious diseases.13 The COVID-19 vaccine is widely recognized as the most promising method for containing or ending the pandemic.1
The finding of the present study revealed that more than half, 226 (56.2%) 95% CI: 51.5; 60.9% of the participants were willing to accept COVID-19 vaccine. Near to half 176 (43.8%) 95% CI: 39.1; 48.5 of the respondents were either refused or hesitated to receive COVID-19 vaccine. This finding matched the findings of studies in France (58.1%),40 USA (53%),37 USA (52.8%),33 Nigeria (55.5%),41 UAE (56.3%),42 Libya (60.9%),13 and Algeria (53.51%).24 The current finding was lower than the study conducted in Italy (86.1%),43 Canada (77.8%),44 16 countries (69.2%),45 Italy (91.9%),46 and Ethiopia (69.3%).36 However, this finding is higher than the study conducted in Gonder, Ethiopia (34.2%).34 In our study, less than 75% of participants were willing to get the COVID-19 vaccination, which is the minimum rate needed to achieve herd immunity and halt the coronavirus outbreak.41 The novelty of COVID-19 disease may be the cause of the poor prevalence of vaccination uptake. Possible reasons for this finding include widespread pandemic conspiracy theories and a psychological need to comprehend numerous pandemic-related occurrences. As a result, particularly in LMIC nations, there may be mistrust and unfavorable perceptions about the vaccine, a lack of faith in the current healthcare system, and information shortages.38 When a safe and effective vaccine is offered for free or at a low cost, the acceptance of the COVID-19 vaccine can rise.47
History of chronic medical illness condition, training towards COVID-19 vaccine, previous history of vaccine uptake, and concern of becoming infected with COVID-19, perception of herd immunity development against COVID-19 and severity of COVID-19 infection were factors significantly associated with the acceptance of COVID-19 vaccine among the participants of the current study. The pandemic of COVID-19 affects all groups of the population. However, literature has revealed that individuals with a history of chronic medical illness conditions are highly vulnerable to developing severe risk of morbidity and mortality due to COVID-19 infection.9,38 The problem is highly severe in developing countries due to the shift of the planned resource budget from routine management of chronic illness disease to the ongoing COVID-19 cases.14 This finding revealed that respondents with a history of chronic medical illness were 4.340 times more likely to accept COVID-19 vaccine than the corresponding groups which was supported by studies conducted in Jordan,48 Bangladesh,49 Italy,46 Mozambique,50 and Ethiopia.51,52
The perception of becoming infected by COVID-19 is an important factor that may motivate individuals to take vaccine against COVID-19.50 The finding of the current study revealed that individuals with the concern of being infected by COVID-19 were 4.109 times more likely to accept the COVID-19 vaccine than the corresponding groups which was supported by the studies conducted in Mozambique,50 Uganda,53 and Nigeria.41 According to literature, knowledge contributes to the judgment on the vaccination concept.12 The finding of the current study revealed that individuals who took training on COVID-19 vaccine were 4.755 times more likely to accept COVID-19 vaccine than the corresponding groups. This finding is in agreement with the study conducted in Ethiopia.38 Participants who had a history of vaccination reluctancy for their children were considerably less likely to take the COVID-19 vaccine. This finding revealed that respondents with a previous history of vaccine uptake were two times more likely to accept COVID-19 vaccine (AOR: 2.534, 95% CI: 1.412, 4.549) than their corresponding groups which was in line with the study conducted in Uganda,53 Switzerland,54 New Jersey,33 and Jordan.55
The vaccine hesitancy affects both the person who refuses to take the vaccine and the entire population, posing a significant challenge to reaching the threshold for conferring COVID-19 herd immunity.12 This study revealed that participants who perceived as they did not develop herd immunity against COVID-19 were two times more likely to accept COVID-19 vaccine (AOR: 2.566, 95% CI: 1.431, 4.599) than the corresponding groups, which was in line with the study conducted in Uganda.56
The strongest predictors of vaccine acceptance included confidence in vaccine safety or effectiveness, worrying about COVID-19, belief in the importance of vaccines to their own country, compliance to mask guidelines, trust of public health agencies/health science, as well as attitudes towards routine vaccines.1 Our study revealed that participants who perceived that COVID-19 is severe infection were four times more likely to accept COVID-19 vaccine (AOR: 4.109, 95% CI: 2.190, 7.710) than the corresponding groups. This is consistent with the findings of Saudi Arabia.57 According to the literature, women were also more likely than men to state that the vaccine was too new that they were fearful of side effects and that they had a medical contraindication to the vaccine.38 However, in our study, it was not statistically significant.
Limitation of the Study
This study has several restrictions. In the beginning, self-administered interviews were used to get the data. The result is flawed by a cross-sectional study design, as is common. In these reports, a longitudinal research might be of utmost value. Additionally, the students who made up the sample are not all population-representative.
Conclusion
In general, the acceptances of COVID-19 vaccine among college students were low which was lower than the vaccination level required for the development of herd immunity. History of chronic medical illness condition, training on COVID-19 vaccine, previous history of vaccine uptake, and concern of becoming infected with COVID-19, perception of herd immunity development against COVID-19 and severity of COVID 19 infection were factors significantly associated with the acceptance of COVID-19 vaccine. Hence, it is necessary to promote COVID-19 vaccination among college students through health education and vaccine outreach. Healthcare practitioners should continuously promote awareness of the COVID-19 vaccine’s significance, safety, and efficacy, with a focus on populations with a higher risk of contracting the disease. Public health authorities must implement systematic measures to lower vaccination reluctance levels and increase vaccine uptake.
Abbreviations
AOR, adjusted odds ratio; COR, crude odds ratio; CI, confidence interval; COVID-19, Corona virus disease 2019; LMIC, low- and middle-income country; SARS COV-2, Severe Acute Respiratory Syndrome COV 2; UAE, United Aram Emirate; USA, United States of America; WHO, World Health Organization.
Data Sharing Statement
The corresponding authors will provide the datasets used and/or analyzed during the current work upon reasonable request.
Acknowledgment
We are grateful to the college students who participated in the study.
Disclosure
The authors report no conflicts of interest in this work.
1. Joshi A, Kaur M, Kaur R, Grover A, Nash D, El-Mohandes A. Predictors of COVID-19 vaccine acceptance, intention, and hesitancy: a scoping review. Front Public Heal. 2021;9. doi:10.3389/fpubh.2021.698111
2. Kaya MO, Yakar B, Pamukçu E, et al. Acceptability of a COVID-19 vaccine and role of knowledge, attitudes and beliefs on vaccination willingness among medical students. Eur Res J. 2021;7(4):417–424. doi:10.18621/eurj.907213
3. Belete ZW, Berihun G, Keleb A, et al. Knowledge, attitude, and preventive practices towards COVID-19 and associated factors among adult hospital visitors in South Gondar Zone Hospitals, Northwest Ethiopia. PLoS One. 2021;16:1–18. doi:10.1371/journal.pone.0250145
4. Umakanthan S, Sahu P, Ranade AV, et al. Origin, transmission, diagnosis and management of coronavirus disease 2019 (COVID-19). Postgrad Med J. 2020;96(1142):753–758. doi:10.1136/postgradmedj-2020-138234
5. Mesesle M. Awareness and attitude towards covid-19 vaccination and associated factors in Ethiopia: cross-sectional study. Infect Drug Resist. 2021;14:2193–2199. doi:10.2147/IDR.S316461
6. Berihun G, Walle Z, Teshome D, et al. Knowledge, attitude, and preventive practices towards COVID-19 among students of Ethiopian higher education institutions. J Multidiscip Healthc. 2021;14:2123–2136. doi:10.2147/JMDH.S322495
7. Feleke A, Adane M, Embrandiri A, et al. Knowledge, attitudes, and misconceptions about COVID-19 prevention practices among high and preparatory school students in Dessie City, Ethiopia. J Multidiscip Healthc. 2022;15:1035–1055. doi:10.2147/JMDH.S325636
8. Umakanthan S, Senthil S, John S, et al. The protective role of statins in COVID-19 patients: a retrospective observational study. Transl Med Commun. 2021;6(1). doi:10.1186/s41231-021-00102-4
9. Ademas A, Adane M, Keleb A, et al. Covid-19 prevention practices and associated factors among diabetes and HIV/AIDS clients in south-wollo zone, Ethiopia: a health facility-based cross-sectional study. J Multidiscip Healthc. 2021;14:2079–2086. doi:10.2147/JMDH.S325207
10. Umakanthan S, Bukelo MM, Gajula SS. The Commonwealth Caribbean COVID-19: regions resilient pathway during pandemic. Front Public Heal. 2022;10:2020–2023.
11. Berihun G, Adane M, Walle Z, et al. Access to and challenges in water, sanitation, and hygiene in healthcare facilities during the early phase of the COVID-19 pandemic in Ethiopia: a mixed-methods evaluation. PLoS One. 2022;17(5):e0268272. doi:10.1371/journal.pone.0268272
12. Magadmi RM, Kamel FO. Beliefs and barriers associated with COVID-19 vaccination among the general population in Saudi Arabia. BMC Public Health. 2021;21(1):1–8. doi:10.1186/s12889-021-11501-5
13. Elhadi M, Alsoufi A, Alhadi A, et al. Knowledge, attitude, and acceptance of healthcare workers and the public regarding the COVID-19 vaccine: a cross-sectional study. BMC Public Health. 2021;21(1):1–21. doi:10.1186/s12889-021-10987-3
14. Baye K. COVID-19 prevention measures in Ethiopia Current realities and prospects. Int Food Policy Res Inst. 2020;14. doi:10.2499/p15738coll2.133729
15. Andualem A, Tegegne B, Ademe S, et al. COVID-19 infection prevention practices among a sample of food handlers of food and drink establishments in Ethiopia. PLoS One. 2022;17(11):1–18. doi:10.1371/journal.pone.0259851
16. Keleb A, Ademas A, Lingerew M, Sisay T, Berihun G, Adane M. Prevention practice of COVID-19 using personal protective equipment and hand hygiene among healthcare workers in public hospitals of South Wollo Zone, Ethiopia. Front Public Heal. 2021;9:1–8.
17. Natnael T, Alemnew Y, Berihun G, et al. Facemask wearing to prevent COVID-19 transmission and associated factors among taxi drivers in Dessie City and Kombolcha Town, Ethiopia. PLoS One. 2021;16(3):e0247954. doi:10.1371/journal.pone.0247954
18. Sarıışık M, Usta S. Global effect of COVID-19. Hosp Tour Ind. 2021;41–59. doi:10.4337/9781800376243.00008
19. Berhanu L, Berihun G, Walle Z, et al. Covid-19 prevention practices and associated factors among farmers in peri-urban areas of northeastern Ethiopia. J Multidiscip Healthc. 2021;14:1843–1852. doi:10.2147/JMDH.S321456
20. Walle Z, Berihun G, Keleb A, Teshome D, Berhanu L. Covid-19 prevention practices and determinant factors among healthcare professionals working in hospitals of south Gondar zone, northwestern Ethiopia. J Multidiscip Healthc. 2021;14:2287–2298. doi:10.2147/JMDH.S325127
21. Lindholt MF, Jørgensen F, Bor A, Petersen MB. Public acceptance of COVID-19 vaccines: cross-national evidence on levels and individual-level predictors using observational data. BMJ Open. 2021;11(6):1–12. doi:10.1136/bmjopen-2020-048172
22. Temsah MH, Barry M, Aljamaan F, et al. Adenovirus and RNA-based COVID-19 vaccines’ perceptions and acceptance among healthcare workers in Saudi Arabia: a national survey. BMJ Open. 2021;11(6):1–9. doi:10.1136/bmjopen-2020-048586
23. Islam MS, Kamal AHM, Kabir A, et al. COVID-19 vaccine rumors and conspiracy theories: the need for cognitive inoculation against misinformation to improve vaccine adherence. PLoS One. 2021;16:1–17. doi:10.1371/journal.pone.0251605
24. Kerdoun MA, Henni AH, Yamoun A, Rahmani A, Kerdoun Ne. RM. COVID-19 vaccine hesitancy among Algerian medical students: a cross-sectional study in five universities. medRxiv. 2021;1–22. doi:10.1101/2021.08.29.21261803
25. Dereje N, Tesfaye A, Tamene B, et al. COVID-19 vaccine hesitancy in Addis Ababa, Ethiopia: a mixed-method study. BMJ Open. 2022;12(5):e052432. doi:10.1136/bmjopen-2021-052432
26. Bayou FD, Amare SN. Acceptance of COVID-19 vaccine and its associated factors among Ethiopian population: a systematic review. Patient Prefer Adherence. 2022;16:1093–1103. doi:10.2147/PPA.S360174
27. Boche B, Kebede O, Damessa M, Gudeta T, Wakjira D. Health professionals’ COVID-19 vaccine acceptance and associated factors in tertiary hospitals of South-West Ethiopia: a multi-center cross- sectional study. Inq. 2022;59:00469580221083181.
28. Belsti Y, Gela YY, Dagnew YAB, et al. Willingness of Ethiopian population to receive COVID-19 vaccine. J Multidiscip Healthc. 2021;14:1233–1243. doi:10.2147/JMDH.S312637
29. Mekonnen BD, Mengistu BA. COVID-19 vaccine acceptance and its associated factors in Ethiopia: a systematic review and meta-analysis. Clin Epidemiol Glob Heal. 2022;14:101001. doi:10.1016/j.cegh.2022.101001
30. World Health Organization. Seventy-Third World Health Assembly. Vol. 1; 2020:18–19.
31. Umakanthan S, Lawrence S. Predictors of COVID-19 vaccine hesitancy in Germany: a cross-sectional, population-based study. Postgrad Med J. 2022;postgradmedj–2021–141365 . doi:10.1136/postgradmedj-2021-141365
32. Umakanthan S, Patil S, Subramaniam N, Sharma R. COVID-19 vaccine hesitancy and resistance in India explored through a population-based longitudinal survey. Vaccines. 2021;9(10):1–11. doi:10.3390/vaccines9101064
33. Kecojevic A, Basch CH, Sullivan M, Chen YT, Davi NK. COVID-19 vaccination and intention to vaccinate among a sample of college students in New Jersey. J Community Health. 2021;46(6):1059–1068. doi:10.1007/s10900-021-00992-3
34. Aklil MB, Temesgan WZ, Gessesse DN, et al. Willingness to receive COVID-19 vaccine and associated factors among college students in Gondar City, Northwest Ethiopia. Front Educ. 2022;7:1–9. doi:10.3389/feduc.2022.799301
35. Sharma M, Davis RE, Wilkerson AH. Covid-19 vaccine acceptance among college students: a theory-based analysis. Int J Environ Res Public Health. 2021;18(9):4617. doi:10.3390/ijerph18094617
36. Taye BT, Amogne FK, Demisse TL, et al. Coronavirus disease 2019 vaccine acceptance and perceived barriers among university students in northeast Ethiopia: a cross-sectional study. Clin Epidemiol Glob Heal. 2021;12:100848. doi:10.1016/j.cegh.2021.100848
37. Lucia VC, Kelekar A, Afonso NM. COVID-19 vaccine hesitancy among medical students. J Public Heal. 2021;43(3):445–449. doi:10.1093/pubmed/fdaa230
38. Berihun G, Walle Z, Berhanu L, Teshome D. Acceptance of covid-19 vaccine and determinant factors among patients with chronic disease visiting Dessie comprehensive specialized hospital, northeastern Ethiopia. Patient Prefer Adherence. 2021;15:1795–1805. doi:10.2147/PPA.S324564
39. Freeman D, Loe BS, Chadwick A, et al. COVID-19 vaccine hesitancy in the UK: the Oxford coronavirus explanations, attitudes, and narratives survey (Oceans) II. Psychol Med. 2021;11:1–5.
40. Tavolacci MP, Dechelotte P, Ladner J. Covid-19 vaccine acceptance, hesitancy, and resistance among university students in France. Vaccines. 2021;9(6):1–13. doi:10.3390/vaccines9060654
41. Adejumo OA, Ogundele OA, Madubuko CR, et al. Perceptions of the COVID-19 vaccine and willingness to receive vaccination among health workers in Nigeria. Osong Public Heal Res Perspect. 2021;12(4):236–243. doi:10.24171/j.phrp.2021.0023
42. Shahwan M, Suliman A, Jairoun AA, et al. Prevalence, knowledge and potential determinants of COVID-19 vaccine acceptability among University Students in the United Arab Emirates: findings and implications. J Multidiscip Healthc. 2022;15:81–92. doi:10.2147/JMDH.S341700
43. Baccolini V, Renzi E, Isonne C, et al. Covid-19 vaccine hesitancy among Italian university students: a cross-sectional survey during the first months of the vaccination campaign. Vaccines. 2021;9(11):11. doi:10.3390/vaccines9111292
44. Mant M, Aslemand A, Prine A, Holland AJ. University students’ perspectives, planned uptake, and hesitancy regarding the COVID-19 vaccine: a multi-methods study. PLoS One. 2021;16:1–16. doi:10.1371/journal.pone.0255447
45. Skjefte M, Ngirbabul M, Akeju O, et al. COVID-19 vaccine acceptance among pregnant women and mothers of young children: results of a survey in 16 countries. Eur J Epidemiol. 2021;36(2):197–211. doi:10.1007/s10654-021-00728-6
46. Gallè F, Sabella EA, Roma P, et al. Knowledge and acceptance of COVID-19 vaccination among undergraduate students from central and southern Italy. Vaccines. 2021;9(6):1–13.
47. Famuyiro TB, Ogunwale A, Des Bordes J, Raji M. COVID-19: perceived infection risk and barriers to uptake of Pfizer-BioNTech and moderna vaccines among community healthcare workers. J Racial Ethn Heal Disparities. 2021;7–12.
48. El-Elimat T, AbuAlSamen MM, Almomani BA, Al-Sawalha NA, Alali FQ. Acceptance and attitudes toward COVID-19 vaccines: a cross-sectional study from Jordan. PLoS One. 2021;16:1–15. doi:10.1371/journal.pone.0250555
49. Akiful Haque MM, Rahman ML, Hossian M, et al. Acceptance of COVID-19 vaccine and its determinants: evidence from a large sample study in Bangladesh. Heliyon. 2021;7(6):e07376. doi:10.1016/j.heliyon.2021.e07376
50. Dula J, Mulhanga A, Nhanombe A, et al. Covid-19 vaccine acceptability and its determinants in Mozambique: an online survey. Vaccines. 2021;9(8):1–10. doi:10.3390/vaccines9080828
51. Abebe H, Shitu S, Mose A. Understanding of COVID-19 vaccine knowledge, attitude, acceptance, and determinates of COVID-19 vaccine acceptance among adult population in Ethiopia. Infect Drug Resist. 2021;14:2015–2025. doi:10.2147/IDR.S312116
52. Zewude B, Habtegiorgis T. Willingness to take COVID-19 vaccine among people most at risk of exposure in Southern Ethiopia. Pragmatic Obs Res. 2021;12:37–47. doi:10.2147/POR.S313991
53. Kanyike AM, Olum R, Kajjimu J, et al. Acceptance of the coronavirus disease-2019 vaccine among medical students in Uganda. Trop Med Health. 2021;49(1):1–11. doi:10.1186/s41182-021-00331-1
54. Dratva J, Wagner A, Zysset A, Volken T. To vaccinate or not to vaccinate—this is the question among Swiss university students. Int J Environ Res Public Health. 2021;18(17):9210. doi:10.3390/ijerph18179210
55. Almaaytah A, Salama A. Acceptance of COVID-19 vaccination among Jordanian adults: a cross sectional study. Syst Rev Pharm. 2020;11(11):1291–1297.
56. Bongomin F, Olum R, Andia-Biraro I, et al. COVID-19 vaccine acceptance among high-risk populations in Uganda. Ther Adv Infect Dis. 2021;8:1–15.
57. Zahid HM, Alsayb MA. Assessing the knowledge and attitude toward COVID-19 vaccination in Saudi Arabia. Int J Environ Res Public Health. 2021;18(15):15. doi:10.3390/ijerph18158185
Gete Berihun,1,* Zebader Walle,2,* Daniel Teshome,3,* Leykun Berhanu,1 Mohammed Derso4
1Department of Environmental Health, College of Medicine and Health Sciences, Wollo University, Dessie, Ethiopia; 2Department of Public Health, College of Health Sciences, Debre Tabor University, Debre Tabor, Ethiopia; 3Department of Anatomy, College of Medicine and Health Sciences, Wollo University, Dessie, Ethiopia; 4Department of Biochemistry, College of Medicine and Health Sciences, Wollo University, Dessie, Ethiopia
*These authors contributed equally to this work
Correspondence: Gete Berihun; Daniel Teshome, Email [email protected]; [email protected]
© 2022. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Details
; Walle, Z
; Teshome, D
; Berhanu, L
; Derso, M